Roche Pharma AG
Roche Pharma AG has 0 FDA recalls, 3 inspections, 0 510(k) clearances and 0 compliance actions on record.
- Latest inspection
- Nov 25, 2016 · VAI
Newer recall under related name Foundation Medicine: Jun 10, 2026, Z-2951-2026.
Reviewing Roche Pharma AG as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Roche Pharma AG yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 4, 2026 (checked Nov 8, 2026, unchanged) | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 0 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 3 | Nov 9, 2026 | Newest record Oct 28, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Related names
| Name | Recalls | 510(k) | Inspections | Compliance | Most recent recall |
|---|---|---|---|---|---|
| Foundation Medicine | 10 | 0 | 8 | 0 | Jun 10, 2026 (Z-2951-2026) |
| Ventana Medical Systems | 42 | 49 | 14 | 0 | Apr 20, 2026 (Z-2913-2026) |
| Roche Diagnostics Operations | 127 | 7 | 9 | 0 | Jan 20, 2026 (Z-1476-2026) |
| Genentech | 11 | 0 | 45 | 0 | May 20, 2024 (D-0509-2024) |
| Roche Diabetes Care | 29 | 13 | 2 | 0 | May 13, 2024 (Z-2174-2024) |
| Roche Molecular Systems | 42 | 55 | 26 | 0 | Dec 21, 2022 (Z-1106-2023) |
| Roche Diagnostics Corporation | 39 | 6 | 0 | 0 | Jun 3, 2019 (Z-1979-2019) |
| Roche Diagnostics | 0 | 457 | 24 | 0 | — |
| Hoffmann La Roche | 0 | 0 | 4 | 0 | — |
| Roche | 0 | 2 | 0 | 0 | — |
| Spark Therapeutics | 0 | 0 | 2 | 0 | — |
| Flatiron Health | 0 | 0 | 1 | 0 | — |
Recent FDA Inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Nov 25, 2016 | Grenzach-Wyhlen, Germany | Drugs | Voluntary Action Indicated (VAI) | 3002807206 |
| Dec 2, 2014 | Grenzach-Wyhlen, Germany | Drugs | Voluntary Action Indicated (VAI) | 3002807206 |
| Sep 21, 2011 | Grenzach-Wyhlen, Germany | Drugs | Voluntary Action Indicated (VAI) | 3002807206 |
FDA-Inspected Facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3002807206 | Grenzach-Wyhlen, Germany | 3 | Nov 25, 2016 |